Intelligent Medicine Acquisition Corp (IQMD) Financials

$11.04

$0.00 (0.00%)

As on 10-May-2023 09:30EDT

Market cap

$65 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

23

P/B Ratio

0

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Operating Expenses	1.30	1.28	--	--	--	--
Operating Profit (EBIT)	-9.90	-14.54	--	--	--	--
Other Income	8.59	13.26	--	--	--	--
Profit before Tax	10.73	11.97	--	--	--	--
Provision for Tax	0.56	0.56	--	--	--	--
Profit after Tax (Net Income)	9.88	11.41	--	--	--	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	7.04	11.41	14.88	--	--	--

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	202.40	202.40	190.99	--	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	10.56	10.56	20.77	--	--	--
Current Liabilities	1.08	1.08	0.24	--	--	--
Total Liabilities	215.11	214.03	211.99	--	--	--

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	213.85	213.85	211.25	--	--	--
Current Assets	0.19	0.19	0.75	--	--	--
Total Assets	214.22	214.03	211.99	--	--	--
Total Debt*	--	--	--	--	--	--
Net Current Assets	--	-0.89	0.51	--	--	--

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-0.87	-365,198.00	--	--	--
Cash Flow from Investing Activities	--	0.34	-253.37	--	--	--
Cash from Financing Activities	--	-0.01	212,094,473.00	--	--	--
Net Cash Inflow / Outflow	--	-0.54	--	--	--	--

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	5.80	--	--	--	--
ROE (%)	4.91	5.80	--	--	--	--
ROA (%)	4.63	5.36	--	--	--	--
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	114.93	86.07	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	1,391.00	-3,772.82	--	--	--	--
Net Profit Growth (%)	-100.00	--	--	--	--	--
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	23.00	--	--	--	--	--
Price / Book Value	--	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	--	--	--	--	--	--
Close Price ($)	10.28	10.28	9.90	--	--	--
High Price ($)	10.34	10.93	10.15	--	--	--
Low Price ($)	9.97	9.86	9.86	--	--	--
Market Cap ($ Cr)	64.75	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	0.17	0.17	3.15	--	--	--
Quick Ratio	0.17	--	--	--	--	--
Interest Coverage	1.62	-0.55	--	--	--	--

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.